Company Filing History:
Years Active: 1992
Title: Liselotte Schellong: Innovator in Fructosamine Determination
Introduction
Liselotte Schellong is a prominent inventor based in Tutzing, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the determination of fructosamine levels in blood samples. Her innovative work has led to the development of a patented process that enhances the accuracy of fructosamine measurement.
Latest Patents
Liselotte Schellong holds a patent for a process and reagent for the specific determination of fructosamine. This process involves the specific determination of serum fructosamine content in blood or samples obtained from blood. The method includes a reaction with an appropriate color reagent and measurement of the resulting color change. Before the color reaction, sample components that exhibit non-specific reducing actions or cause turbidity are removed. The color reagent is then added at a pH value ranging from 10 to 12. The removal of sample components is achieved by treating the sample at approximately neutral pH with a reagent composition that includes at least one enzymatic oxidation agent, optionally combined with peroxidase, catalase, or lipase, along with at least one SH group-blocking substance. Additionally, a kit for the specific determination of serum fructosamine content comprises the reagent composition, a rebuffering reagent with an alkaline pH buffer, and a color reagent for fructosamine detection.
Career Highlights
Liselotte Schellong has had a distinguished career, working at Boehringer Mannheim GmbH, where she has contributed to advancements in medical diagnostics. Her innovative approach to fructosamine determination has positioned her as a key figure in her field.
Collaborations
Throughout her career, Liselotte has collaborated with notable colleagues, including Bernd Vogt and Joachim Siedel. These collaborations have further enhanced her research and development efforts in medical diagnostics.
Conclusion
Liselotte Schellong's contributions to the field of medical diagnostics, particularly through her patented process for fructosamine determination, highlight her innovative spirit and dedication to improving healthcare. Her work continues to impact the accuracy of blood sample analysis, showcasing the importance of innovation in medical science.